Abstract
In the present study we have evaluated the effect of a single hemodialysis session on the brain-derived neurotrophic factor levels in plasma [BDNF]pl and in serum [BDNF]s as well as on the plasma isoprostanes concentration [F2 isoprostanes]pl, plasma total antioxidant capacity (TAC) and plasma cortisol levels in chronic kidney disease patients. Twenty male patients (age 69.8 ± 2.9 years (mean ± SE)) with end-stage renal disease undergoing maintenance hemodialysis on regular dialysis treatment for 15–71 months participated in this study. A single hemodialysis session, lasting 4.2 ± 0.1 h, resulted in a decrease (P = 0.014) in [BDNF]s by ~42 % (2,574 ± 322 vs. 1,492 ± 327 pg ml−1). This was accompanied by an increase (P < 10−4) of [F2-Isoprostanes]pl (38 ± 3 vs. 116 ± 16 pg ml−1), decrease (P < 10−4) in TAC (1,483 ± 41 vs. 983 ± 35 trolox equivalents, μmol l−1) and a decrease (P = 0.004) in plasma cortisol level (449.5 ± 101.2 vs. 315.3 ± 196.3 nmol l−1). No changes (P > 0.05) in [BDNF]pl and the platelets count were observed after a single dialysis session. Furthermore, basal [BDNF]s in the chronic kidney disease patients was significantly lower (P = 0.03) when compared to the age-matched control group (n = 23). We have concluded that the observed decrease in serum BDNF level after hemodialysis accompanied by elevated [F2-Isoprostanes]pl and decreased plasma TAC might be caused by enhanced oxidative stress induced by hemodialysis.
Similar content being viewed by others
References
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152
Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22:123–131
Kozisek ME, Middlemas D, Bylund DB (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117:30–51
Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R (1999) An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer’s disease. Neuroscience 88:1015–1032
Lamballe F, Klein R, Barbacid M (1991) TrkC, a new member of the Trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66:967–979
Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, Lassi NK (1997) Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 30:347–374
Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD (2002) From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 9:224–237 Review
Noble EE, Billington CJ, Kotz CM, Wang C (2011) The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 300:R1053–R1069
Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553–1561
Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123
Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM (2007) Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 73:143–149
Yamamoto H, Gurney ME (1990) Human platelets contain brain-derived neurotrophic factor. J Neurosci 10:3469–3478
Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728–734
Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264
Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270–276
Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B, Bernard C, Benoliel JJ, Becker C (2011) Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 31:12889–12899
Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113–137
Kermani P, Hempstead B (2007) Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 17:140–143
Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: aneuroprotective role of inflammation? J Exp Med 189:865–870
Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431–438
Fujinami A, Ohta K, Obayashi H, Fukui M, Hasegawa G, Nakamura N, Kozai H, Imai S, Ohta M (2008) Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 41:812–817
Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J, Burton LE, Stanton BR, Kaplan DR, Hunter T, Nikolics K, Parada LF (1991) The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the TrkB tyrosine kinase receptor. Cell 65:895–903
Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101:10827–10832
Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597–606
Duman RS, Malberg J, Nakagawa S, D’Sa C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732–739
Shoval G, Weizman A (2005) The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol 15:319–329
Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381–386
Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A (2007) Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1023–1026
Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH (2007) Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 31:78–85
Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, Ueda N, Nakamura J (2007) Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31:1034–1037
Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V (2007) Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington’s disease patients. Am J Med Genet B Neuropsychiatr Genet 144B:574–577
Cukor D, Coplan J, Brown C, Peterson RA, Kimmel PL (2008) Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Clin J Am Soc Nephrol 3:1752–1758
Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H, Griffith JL, Sarnak MJ (2010) Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 56:704–712
Daugirdas JT, Van Stone JC, Boag JT (2001) Physiologic principles and urea kinetic modeling. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of dialysis, 3rd edn. Lippincott Williams & Wilkins, Baltimore MD, p 29
Bartosz G, Bartosz M (1999) Antioxidant activity: what do we measure? Acta Biochim Pol 46:23–29
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237
Bartosz G (2003) The other face of oxygen. Free radicals in nature. Polish Scientific Publishers (PWN), Warsaw, pp 389–391
Dill DB, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37:247–248
Berthoin S, Pelayo P, Baquet G, Marais G, Allender H, Robin H (2002) Plasma lactate recovery from maximal exercise with correction for variations in plasma volume. J Sports Med Phys Fitness 42:26–30
McAllister AK, Katz LC, Lo DC (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295–318
Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B (1996) Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381:706–709
Kafitz KW, Rose CR, Thoenen H, Konnerth A (1999) Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401:918–921
Alonso M, Vianna MR, Izquierdo I, Medina JH (2002) Signaling mechanisms mediating BDNF modulation of memory formation in vivo in the hippocampus. Cell Mol Neurobiol 22:663–674
Kossel AH, Cambridge SB, Wagner U, Bonhoeffer T (2001) A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation. Proc Natl Acad Sci USA 98:14702–14707 Erratum in: Proc Natl Acad Sci USA (2002) 99:541
Lee JL, Everitt BJ, Thomas KL (2004) Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 304:839–843
Santhanam AV, Smith LA, Katusic ZS (2010) Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 41:350–356
Gryglewski RJ (1980) Prostaglandins, platelets, and atherosclerosis. CRC Crit Rev Biochem 7:291–338
Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116:4–15
Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, Adamus J, Gebicki J (2007) 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol 152:230–239
Zoladz JA, Majerczak J, Duda K, Chłopicki S (2010) Endurance training increases exercise-induced prostacyclin release in young, healthy men-relationship with VO2max. Pharmacol Rep 62:494–502
Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, Sarnak MJ (2011) Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 58:773–781
Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, Valentino V, Luisi S, Luisi M, Genazzani AR (2008) Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 197:429–435
Choi SW, Bhang S, Ahn JH (2011) Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects. Psychiatry Res 186:427–430
Braun A, Lommatzsch M, Mannsfeldt A, Neuhaus-Steinmetz U, Fischer A, Schnoy N, Lewin GR, Renz H (1999) Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol 4:537–546
Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F (2003) Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 57:493–497
Lee DM, Jackson KW, Knowlton N, Wages J, Alaupovic P, Samuelsson O, Saeed A, Centola M, Attman PO (2011) Oxidative stress and inflammation in renal patients and healthy subjects. PLoS ONE 6:e22360
Montuschi P, Barnes PJ, Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791–1800
Zanetti M, Barazzoni R, Gortan Cappellari G, Burekovic I, Bosutti A, Stocca A, Bianco F, Ianche M, Panzetta G, Guarnieri G (2011) Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation. J Ren Nutr 21:401–409
Errakonda PR, Paladugu R, Bitla AR, Musturu SM, Lakshman J, Pemmaraju SR, Vishnubhotla S (2011) Effect of a single hemodialysis session on endothelial dysfunction. J Nephrol 24:83–90
Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A (2011) Oxidative stress and inflammation: implications in uremia and hemodialysis. Clin Biochem 44:1189–1198
Zhao HF, Li Q, Li Y (2011) Long-term ginsenoside administration prevents memory loss in aged female C57BL/6 J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus. Neuroscience 183:189–202
You Z, Luo C, Zhang W, Chen Y, He J, Zhao Q, Zuo R, Wu Y (2011) Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res 225:135–141
Neeper SA, Gómez-Pinilla F, Choi J, Cotman C (1995) Exercise and brain neurotrophins. Nature 373:109
Liu YF, Chen HI, Wu CL, Kuo YM, Yu L, Huang AM, Wu FS, Chuang JI, Jen CJ (2009) Differential effects of treadmill running and wheel running on spatial or aversive learning and memory: roles of amygdalar brain-derived neurotrophic factor and synaptotagmin I. J Physiol 587:3221–3231
Zoladz JA, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, Duda K (2008) Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol 59(Suppl 7):119–132
Rojas Vega S, Abel T, Lindschulten R, Hollmann W, Bloch W, Strüder HK (2008) Impact of exercise on neuroplasticity-related proteins in spinal cord injured humans. Neuroscience 153:1064–1070
Matthews VB, Aström MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerström T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA (2009) Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52:1409–1418
Ferris LT, Williams JS, Shen CL (2007) The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc 39:728–734
Zoladz JA, Pilc A (2010) The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. J Physiol Pharmacol 61:533–541
Acknowledgments
We thank the patients for their kind cooperation in this study. We also gratefully acknowledge the financial support of the Ministry of Science and Higher Education (Poland) (grant number 245/KFiB/2009) for this project.
Conflict of interest
All the authors declared no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zoladz, J.A., Śmigielski, M., Majerczak, J. et al. Hemodialysis Decreases Serum Brain-Derived Neurotrophic Factor Concentration in Humans. Neurochem Res 37, 2715–2724 (2012). https://doi.org/10.1007/s11064-012-0862-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-012-0862-6